Suppr超能文献

通过用放射性标记的血浆前激肽释放酶或因子XI进行配体印迹法检测和定量血浆中裂解和未裂解的高分子量激肽原。

Detection and quantitation of cleaved and uncleaved high molecular weight kininogen in plasma by ligand blotting with radiolabeled plasma prekallikrein or factor XI.

作者信息

Lämmle B, Zuraw B L, Heeb M J, Schwarz H P, Berrettini M, Curd J G, Griffin J H

机构信息

Department of Immunology, Scripps Clinic and Research Foundation, La Jolla, CA 92037.

出版信息

Thromb Haemost. 1988 Apr 8;59(2):151-61.

PMID:3388291
Abstract

A method for the quantitative assay of native single chain and kallikrein cleaved two-chain high molecular weight (HMW)-kininogen in plasma is described. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) of whole plasma is followed by electrotransfer of the electropherogram to nitrocellulose membranes and detection of the blotted HMW-kininogen with its physiologic ligands, radiolabeled plasma prekallikrein or radiolabeled factor XI. Using unreduced SDS-PAGE cleaved two-chain HMW-kininogen (Mr approximately 107,000 and 95,000), is electrophoretically separated from uncleaved single chain HMW-kininogen (Mr approximately 150,000). Counting the radioactivity of the nitrocellulose pieces corresponding to cleaved HMW-kininogen permits its quantitative measurement by comparison with standards consisting of decreasing amounts of fully dextran sulfate activated normal human plasma. Single chain HMW-kininogen is similarly assayed using reduced SDS-PAGE and unactivated normal human plasma standards. This technique is highly specific and sensitive to about 50 ng of either cleaved or uncleaved HMW-kininogen. Varying amounts of cleaved HMW-kininogen were found in a small series of plasmas from patients suffering from various inflammatory conditions. Higher levels of in vivo cleaved HMW-kininogen were observed during acute attacks of hereditary angioedema due to Cl-inhibitor deficiency. This technique may be useful for the assessment of the degree of in vitro or in vivo activation of the contact system.

摘要

本文描述了一种定量检测血浆中天然单链和激肽释放酶裂解的双链高分子量(HMW)-激肽原的方法。对全血浆进行十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE),然后将电泳图谱电转移至硝酸纤维素膜上,并用其生理配体、放射性标记的血浆前激肽释放酶或放射性标记的因子XI检测印迹的HMW-激肽原。使用未还原的SDS-PAGE,裂解的双链HMW-激肽原(分子量约为107,000和95,000)可与未裂解的单链HMW-激肽原(分子量约为150,000)进行电泳分离。通过对与裂解的HMW-激肽原相对应的硝酸纤维素片的放射性计数,与由逐渐减少量的完全硫酸葡聚糖激活的正常人血浆组成的标准品进行比较,可对其进行定量测量。单链HMW-激肽原同样采用还原的SDS-PAGE和未激活的正常人血浆标准品进行检测。该技术具有高度特异性,对约50 ng的裂解或未裂解的HMW-激肽原均敏感。在一小系列患有各种炎症性疾病患者的血浆中发现了不同量的裂解HMW-激肽原。在因C1抑制剂缺乏导致的遗传性血管性水肿急性发作期间,观察到体内裂解的HMW-激肽原水平较高。该技术可能有助于评估接触系统的体外或体内激活程度。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验